Stockscreener 앱 받기
1.43
5.92%
-0.09
전일 마감가:
$1.52
열려 있는:
$1.52
하루 거래량:
28,783
Relative Volume:
0.40
시가총액:
$2.22M
수익:
-
순이익/손실:
$-53.12M
주가수익비율:
-0.0131
EPS:
-108.8
순현금흐름:
$-15.86M
1주 성능:
-19.21%
1개월 성능:
-38.63%
6개월 성능:
-69.25%
1년 성능:
-95.19%
1일 변동 폭
$1.415
$1.52
1주일 범위
$1.415
$1.79
52주 변동 폭
$1.415
$179.35
블루 워터 백신 Stock (ONCO) Company Profile
명칭
Onconetix Inc
전화
513-620-4101
주소
201 E. FIFTH STREET, CINCINNATI
ONCO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
1.43 | 2.36M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.90 | 117.47B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.97 | 82.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.59 | 52.94B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
844.92 | 52.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.88 | 37.84B | 447.02M | -1.18B | -906.14M | -6.1812 |
블루 워터 백신 주식(ONCO)의 최신 뉴스
Why Onconetix Inc. (J4T) stock signals breakout potential2025 Historical Comparison & Expert Approved Momentum Ideas - Улправда
Will Onconetix Inc. stock maintain growth storyMarket Activity Recap & Daily Profit Focused Stock Screening - Улправда
Onconetix settles with IQVIA, adjusts accounts payable - MSN
Is Onconetix Inc. (J4T) stock undervalued at current priceEarnings Overview Summary & Verified Swing Trading Watchlist - Улправда
Published on: 2025-12-20 23:06:18 - moha.gov.vn
How dovish Fed policy supports Onconetix Inc. (J4T) stockJuly 2025 EndofMonth & Weekly Return Optimization Plans - Улправда
Is Onconetix Inc. stock positioned well for digital economyWeekly Market Summary & High Conviction Buy Zone Alerts - Улправда
Onconetix (NASDAQ: ONCO) details 29.8M-share resale, PIPE dilution and going concern risk - Stock Titan
What Wall Street predicts for Onconetix Inc. stock pricePortfolio Return Summary & Real-Time Market Sentiment Reports - Улправда
Is Onconetix Inc. stock supported by strong fundamentalsBull Run & Weekly High Potential Alerts - Улправда
Can Onconetix Inc. stock hit analyst price targetsShare Buyback & Stepwise Trade Signal Implementation - DonanımHaber
Can Onconetix Inc. stock reach $100 price target2025 Macro Impact & Safe Swing Trade Setup Alerts - DonanımHaber
How Onconetix Inc. (J4T) stock expands through international marketsMarket Activity Report & Community Trade Idea Sharing Platform - Улправда
Will Onconetix Inc. stock benefit from commodity pricesEarnings Miss & Weekly High Potential Stock Alerts - Улправда
Insider Buy: Will Onconetix Inc. stock maintain growth storyQuarterly Risk Review & Verified Swing Trading Watchlist - Улправда
Is Onconetix Inc. stock trading at a premium valuationJuly 2025 Highlights & Verified Swing Trading Watchlist - Улправда
Is Onconetix Inc a good long term investmentVolume Profile Analysis & Capital Allocation Recommendations - earlytimes.in
Winners Losers: Is Onconetix Inc stock affected by interest rate hikesTrade Risk Summary & Low Risk Investment Opportunities - moha.gov.vn
History Review: Why Onconetix Inc. (J4T) stock signals breakout potentialWeekly Gains Report & Free Community Supported Trade Ideas - moha.gov.vn
Onconetix Inc Stock Analysis and ForecastTop Performing Stocks & Backtest Your Strategy Before You Risk Money - earlytimes.in
Onconetix, Inc. (ONCO) director discloses zero share ownership as of December 5, 2025 - Stock Titan
Onconetix amends license agreement with Labcorp - MSN
Onconetix Approves CEO Bonus and Stockholder Proposals - TipRanks
Onconetix Amends License Agreement with Labcorp - TipRanks
Guidance Update: Why Onconetix Inc J4T stock signals breakout potentialWeekly Stock Recap & Growth Oriented Trade Recommendations - BỘ NỘI VỤ
Is Onconetix Inc. (J4T) stock worth holding before Fed meetingOil Prices & Verified Technical Signals - Newser
Will Onconetix Inc. (J4T) stock enhance shareholder valueWeekly Trade Summary & Community Consensus Picks - Newser
Is Onconetix Inc. (J4T) stock supported by strong fundamentals2025 Valuation Update & Long Hold Capital Preservation Tips - Newser
Is Onconetix Inc. (J4T) stock resilient in recession scenarios2025 Investor Takeaways & Real-Time Chart Breakout Alerts - Newser
Why pension funds invest in Onconetix Inc. (J4T) stockTrade Volume Report & AI Driven Stock Reports - Newser
What insider purchases suggest about Onconetix Inc. (J4T) stockJuly 2025 Trends & Safe Capital Growth Plans - Newser
Can Onconetix Inc. (J4T) stock sustain margin levelsEarnings Beat & Long-Term Growth Stock Strategies - Newser
Onconetix, Inc. (ONCO) -6.5% in After-hours: Amid Routine Trading Conditions - Stocks Telegraph
Total debt per share of Onconetix Inc – MUN:J4T - TradingView
Working capital per share of Onconetix Inc – MUN:J4T - TradingView
Oncopeptides announces the Nomination Committee - MarketScreener
ONCO SEC FilingsOnconetix 10-K, 10-Q, 8-K Forms - Stock Titan
Can you recover from losses in Onconetix Inc.2025 Market Sentiment & Fast Moving Trade Plans - newser.com
Will Onconetix Inc. (J4T) stock announce special dividendSell Signal & Daily Growth Stock Investment Tips - newser.com
Will Onconetix Inc. (J4T) stock profit from fiscal stimulus2025 Retail Activity & Stepwise Trade Execution Plans - newser.com
Tools to assess Onconetix Inc.’s risk profileJuly 2025 Momentum & AI Enhanced Execution Alerts - newser.com
What’s the recovery path for long term holders of Onconetix Inc.2025 Support & Resistance & Safe Entry Trade Signal Reports - newser.com
Will Onconetix Inc. (J4T) stock draw ESG focused fundsJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com
Why analysts upgrade Onconetix Inc. stockJuly 2025 Summary & Trade Opportunity Analysis Reports - newser.com
Order flow analysis tools used on Onconetix Inc.Analyst Upgrade & Momentum Based Trading Signals - newser.com
What hedge fund activity signals for Onconetix Inc. stock2025 Geopolitical Influence & Weekly Breakout Watchlists - newser.com
Can Onconetix Inc. (J4T) stock resist broad market declinesBuy Signal & Momentum Based Trading Ideas - newser.com
블루 워터 백신 (ONCO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
0.21%
자본화:
|
볼륨(24시간):